Landscapes / Digestive Signs and Symptoms / Mental Disorders

Feeding and Eating Disorders

1 drug in active Feeding and Eating Disorders trials · Updated 20 Nov 2026

Furthest along
1 in Phase 3
Next Phase 3 result
Dec 2026
Drugs
1
In active trials, any stage
Trials
2 active
2 sub-diseases included

Drugs1

DrugHow it worksCompanyStageNext dateDetails
Dopamine and norepinephrine reuptake inhibitor
Phase 3 Dec 2026Phase 3 trial completes

Included2

Sub-diseaseDrugsActive trialsTrials
Binge-Eating Disorder12

1 more with no active trials: Anorexia Nervosa

About

Summary
1 drug is in active Feeding and Eating Disorders trials. The next Phase 3 result expected is Solriamfetol’s, Dec 2026. Updated 20 Nov 2026.
Registry term
Feeding and Eating Disorders
Counts
Active trials the registry tags with the term or a term under it, at any stage. A search also reads trial titles and drug names, so its counts differ.
Sources
ClinicalTrials.gov updated 20 Nov 2026